Adolescent Medicine
Latest News
FDA mandates five changes to iPLEDGE program for isotretinoin
The changes follow a March 2023 meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs...
Latest News
Laser epilation may reduce pilonidal disease recurrences when added to standard care
The study is “the first, to our knowledge, to compare LE as an adjunct to standard care versus standard care alone and demonstrate a decrease in...
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Latest News
Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis
Lebrikizumab remains under review in the United States.
News from the FDA/CDC
New at-home test approved for chlamydia and gonorrhea
“This authorization marks an important public health milestone, giving patients more information about their health from the privacy of their own...
Latest News
Systematic review spotlights the use of nutraceuticals for acne
Zinc was the most studied nutraceutical, but there was substantial heterogeneity in the results.
Latest News
FDA approves fixed dose combination topical treatment for acne
The new treatment combines three approved acne products for once-daily use.
News from the FDA/CDC
New meningococcal vaccine wins FDA approval
The vaccine “has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest...
Commentary
Why legal pot makes this physician sick
Cannabis-related emergency department visits from all acute-care hospitals in California increased by 1,808% from 2005 to 2019 in patients aged 65...
Latest News
Once-weekly topical therapy shows promise for moderate to severe acne
In vitro studies have found that components of S. lacustris, a freshwater sponge, have effects that include antimicrobial activity...
Conference Coverage
Asthma severity higher among LGBTQ+ population
SGM respondents were significantly more likely to have had asthma attacks requiring steroid use in the past years.